These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Neurite Collapse and Altered ER Ca Korecka JA; Talbot S; Osborn TM; de Leeuw SM; Levy SA; Ferrari EJ; Moskites A; Atkinson E; Jodelka FM; Hinrich AJ; Hastings ML; Woolf CJ; Hallett PJ; Isacson O Stem Cell Reports; 2019 Jan; 12(1):29-41. PubMed ID: 30595548 [TBL] [Abstract][Full Text] [Related]
8. In Vitro Modeling of Leucine-Rich Repeat Kinase 2 G2019S-Mediated Parkinson's Disease Pathology. Vermilyea SC; Emborg ME Stem Cells Dev; 2018 Jul; 27(14):960-967. PubMed ID: 29402177 [TBL] [Abstract][Full Text] [Related]
9. In vitro genome editing rescues parkinsonism phenotypes in induced pluripotent stem cells-derived dopaminergic neurons carrying LRRK2 p.G2019S mutation. Chang KH; Huang CY; Ou-Yang CH; Ho CH; Lin HY; Hsu CL; Chen YT; Chou YC; Chen YJ; Chen Y; Lin JL; Wang JK; Lin PW; Lin YR; Lin MH; Tseng CK; Lin CH Stem Cell Res Ther; 2021 Sep; 12(1):508. PubMed ID: 34551822 [TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of amyloid precursor protein by mutant LRRK2 promotes AICD activity and neurotoxicity in Parkinson's disease. Chen ZC; Zhang W; Chua LL; Chai C; Li R; Lin L; Cao Z; Angeles DC; Stanton LW; Peng JH; Zhou ZD; Lim KL; Zeng L; Tan EK Sci Signal; 2017 Jul; 10(488):. PubMed ID: 28720718 [TBL] [Abstract][Full Text] [Related]
11. Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression. Liu G; Sgobio C; Gu X; Sun L; Lin X; Yu J; Parisiadou L; Xie C; Sastry N; Ding J; Lohr KM; Miller GW; Mateo Y; Lovinger DM; Cai H Hum Mol Genet; 2015 Sep; 24(18):5299-312. PubMed ID: 26123485 [TBL] [Abstract][Full Text] [Related]
12. Lovastatin protects neurite degeneration in LRRK2-G2019S parkinsonism through activating the Akt/Nrf pathway and inhibiting GSK3β activity. Lin CH; Lin HI; Chen ML; Lai TT; Cao LP; Farrer MJ; Wu RM; Chien CT Hum Mol Genet; 2016 May; 25(10):1965-1978. PubMed ID: 26931464 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of excessive mitochondrial fission reduced aberrant autophagy and neuronal damage caused by LRRK2 G2019S mutation. Su YC; Qi X Hum Mol Genet; 2013 Nov; 22(22):4545-61. PubMed ID: 23813973 [TBL] [Abstract][Full Text] [Related]
14. Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity. Nguyen APT; Tsika E; Kelly K; Levine N; Chen X; West AB; Boularand S; Barneoud P; Moore DJ Proc Natl Acad Sci U S A; 2020 Jul; 117(29):17296-17307. PubMed ID: 32631998 [TBL] [Abstract][Full Text] [Related]
15. Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2 Juárez-Flores DL; González-Casacuberta I; Ezquerra M; Bañó M; Carmona-Pontaque F; Catalán-García M; Guitart-Mampel M; Rivero JJ; Tobias E; Milisenda JC; Tolosa E; Marti MJ; Fernández-Santiago R; Cardellach F; Morén C; Garrabou G J Transl Med; 2018 Jun; 16(1):160. PubMed ID: 29884186 [TBL] [Abstract][Full Text] [Related]
16. Parkinson's Disease-Associated LRRK2 Hyperactive Kinase Mutant Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons. Pan PY; Li X; Wang J; Powell J; Wang Q; Zhang Y; Chen Z; Wicinski B; Hof P; Ryan TA; Yue Z J Neurosci; 2017 Nov; 37(47):11366-11376. PubMed ID: 29054882 [TBL] [Abstract][Full Text] [Related]
17. The LRRK2 G2019S mutation alters astrocyte-to-neuron communication via extracellular vesicles and induces neuron atrophy in a human iPSC-derived model of Parkinson's disease. de Rus Jacquet A; Tancredi JL; Lemire AL; DeSantis MC; Li WP; O'Shea EK Elife; 2021 Sep; 10():. PubMed ID: 34590578 [TBL] [Abstract][Full Text] [Related]